🎉 M&A multiples are live!
Check it out!

Public Comps and Valuation Multiples
for Pharma Diagnostics & Analytics

Benchmark revenue and EBITDA valuation multiples for public comps like Bioventix, Adaptive Biotech, Bio-Techne, Sepax Technologies and Biohit.

Pharma Diagnostics & Analytics

See analyst estimates and all valuation multiples for Pharma Diagnostics & Analytics
Company EV EV/Revenue EV/EBITDA
$11.7B n/a n/a
$7.9B 6.5x 18.8x
$1.3B 6.8x -20.7x
$1.2B 4.6x -8.3x
$891M n/a n/a
$197M 10.8x 14.2x
$181M 8.3x -5.7x
$160M n/a n/a
$40.7M 2.3x 12.6x
$35.5M 14.6x -8.9x
$21.3M 18.1x -9.0x
$10.6M n/a n/a
-$13.9M -0.5x n/a
-$15.0M n/a 0.2x

Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.

See analyst estimates and M&A multiples for Pharma Diagnostics & Analytics

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.